Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,074
Total Claims
$828K
Drug Cost
457
Beneficiaries
$1,811
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-95%
Opioid rate vs peers
0.1% vs 2.5% avg
+61%
Cost per patient vs peers
$1,811 vs $1,128 avg
+131%
Brand preference vs peers
19.4% vs 8.4% avg
Opioid Prescribing
0.1%
Opioid Rate
12
Opioid Claims
$54
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,731 claims · $712K
Generic: 7,175 claims · $111K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapaglifloz Propaned/Metformin | 202 | $126K |
| Dapagliflozin Propanediol | 175 | $123K |
| Apixaban | 76 | $58K |
| Insulin Glargine,hum.Rec.Anlog | 131 | $55K |
| Sitagliptin Phos/Metformin Hcl | 45 | $36K |
| Sitagliptin Phosphate | 55 | $32K |
| Dulaglutide | 27 | $27K |
| Rivaroxaban | 32 | $27K |
| Empagliflozin | 32 | $25K |
| Levothyroxine Sodium | 327 | $24K |
| Insulin Lispro | 31 | $21K |
| Insulin Nph Hum/Reg Insulin Hm | 34 | $13K |
| Mesalamine | 11 | $9,194 |
| Insulin Lispro | 14 | $9,147 |
| Insulin Glargine,hum.Rec.Anlog | 20 | $8,563 |
Prescribing Profile
Patient Profile
73
Avg Age
60%
Female
1.88
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data